Identification of medically actionable secondary findings in the 1000 genomes

Authors

Emily Olfson, Washington University School of Medicine in St. Louis
Catherine E. Cottrell, Washington University School of Medicine in St. Louis
Nicholas O. Davidson, Washington University School of Medicine in St. LouisFollow
Christina A. Gurnett, Washington University School of Medicine in St. Louis
Jonathan W. Heusel, Washington University School of Medicine in St. Louis
Nathan O. Stitziel, Washington University School of Medicine in St. Louis
Li-Shiun Chen, Washington University School of Medicine in St. Louis
Sarah Hartz, Washington University School of Medicine in St. LouisFollow
Rakesh Nagarajan, Washington University School of Medicine in St. Louis
Nancy L. Saccone, Washington University School of Medicine in St. Louis
Laura J. Bierut, Washington University School of Medicine in St. LouisFollow

Journal

PLoS One

Publication Date

2015

Volume

10

Issue

9

Inclusive Pages

e0135193

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0135193

Rights and Permissions

Olfson E, Cottrell CE, Davidson NO, Gurnett CA, Heusel JW, et al. (2015) Identification of medically actionable secondary findings in the 1000 genomes. PLoS ONE 10(9): e0135193. doi: 10.1371/journal.pone.0135193

Recommended Citation

Olfson, Emily; Cottrell, Catherine E.; Davidson, Nicholas O.; Gurnett, Christina A.; Heusel, Jonathan W.; Stitziel, Nathan O.; Chen, Li-Shiun; Hartz, Sarah; Nagarajan, Rakesh; Saccone, Nancy L.; and Bierut, Laura J., "Identification of medically actionable secondary findings in the 1000 genomes." PLoS One. 10, 9. e0135193. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4197